PTC Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	984.65	779.71	594	279.83	189.72
Short-Term Investments	960.72	359.99	282.74	130.87	583.66
Cash & Short-Term Investments	1,945	1,140	876.74	410.71	773.38
Cash Growth	70.69%	29.99%	113.47%	-46.89%	-29.93%
Accounts Receivable	181.62	158.55	160.82	155.61	110.46
Inventory	79.65	23.19	30.58	21.81	15.86
Other Current Assets	67.31	44.09	150.49	105.66	54.68
Total Current Assets	2,274	1,366	1,219	693.79	954.37
Net Property, Plant & Equipment	135.42	117.66	178.99	175.02	130.01
Other Intangible Assets	388.75	118.79	379.5	705.89	724.84
Goodwill	82.34	82.34	82.34	82.34	82.34
Other Long-Term Assets	18.3	20.7	36.25	48.58	46.5
Total Assets	2,899	1,705	1,896	1,706	1,938
Accounts Payable	381.27	304.29	391.98	320.37	288.78
Current Portion of Long-Term Debt	286.63	-	-	-	149.54
Current Portion of Leases	15.48	13.36	16	12.37	10.27
Unearned Revenue	2.04	5.51	0.8	1.35	-
Other Current Liabilities	283	257.82	194.31	72.15	60.75
Total Current Liabilities	968.43	580.98	603.1	406.24	509.35
Long-Term Debt	-	285.41	284.21	571.72	281.89
Long-Term Leases	96.58	90.52	114.81	119.54	93.67
Other Long-Term Liabilities	2,039	1,846	1,712	955.21	1,052
Total Long-Term Liabilities	2,136	2,222	2,111	1,646	1,427
Total Liabilities	3,104	2,803	2,714	2,053	1,937
Common Stock	0.08	0.08	0.08	0.07	0
Additional Paid-in Capital	2,748	2,575	2,466	2,305	2,124
Accumulated Other Comprehensive Income	10.5	-25.89	-1.29	4.8	-24.28
Retained Earnings	-2,964	-3,647	-3,284	-2,657	-2,098
Shareholders' Equity	-205.31	-1,098	-818.56	-347.09	1.37
Total Liabilities & Equity	2,899	1,705	1,896	1,706	1,938
Total Debt	398.7	389.3	415.03	703.63	535.38
Net Cash (Debt)	1,547	750.4	461.71	-292.92	238
Net Cash Growth	106.11%	62.52%	-	-	-65.16%
Net Cash Per Share	17.51	9.77	6.17	-4.08	3.38
Book Value	-205.31	-1,098	-818.56	-347.09	1.37
Book Value Per Share	-2.32	-14.29	-10.94	-4.84	0.02
Tangible Book Value	-676.41	-1,299	-1,280	-1,135	-805.81
Tangible Book Value Per Share	-7.66	-16.91	-17.11	-15.83	-11.44

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q